Real-Life Evidence for Using a Treat-and-Extend Injection Regime for Patients with Central Retinal Vein Occlusion

INTRODUCTION: To report the 52-week treatment outcomes with intravitreal injections of aflibercept using a treat-and-extend regimen for treating macular edema secondary to central retinal vein occlusion (CRVO). METHODS: A retrospective analysis of patients newly diagnosed with CRVO was performed. Pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Eleftheriadou, Maria, Nicholson, Luke, D’Alonzo, Giulia, Addison, Peter K. F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6514015/
https://www.ncbi.nlm.nih.gov/pubmed/30969404
http://dx.doi.org/10.1007/s40123-019-0184-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6514015/
https://www.ncbi.nlm.nih.gov/pubmed/30969404
http://dx.doi.org/10.1007/s40123-019-0184-8

Ejemplares similares